Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Danaher Corporation (DHR) vs Western Alliance Bancorporation (WAL) Price & Performance

Danaher CorporationTrade
Western Alliance BancorporationTrade

Price performance (Past 24H)

Key statistics

Danaher Corporation vs Western Alliance Bancorporation — how do they compare? Danaher Corporation trades at $217 (market cap $153.60B), while Western Alliance Bancorporation trades at $76.21 (market cap $8.11B). The key difference: Danaher Corporation is far larger — about 18.9× Western Alliance Bancorporation's market cap, and Western Alliance Bancorporation pays the higher dividend (2.26%). Which is the better fit depends on your goals — on Pluang, investors hold Danaher Corporation for 69 Days and Western Alliance Bancorporation for 3 Days on average.

DHRWAL
Market Cap
$153.60B$8.11B
Volume
3,974,0631,479,953
Sector
HealthFinancials
52-Week High
$242.05$96.08
52-Week Low
$161.91$66.70
Typical Hold Time
69 Days3 Days
Enterprise Value
$175.81B$9.63B
Dividend Yield
0.73%2.26%

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

Danaher Corporation

Danaher (DHR) trades at $217.46, up 0.88% on the day, with a bullish technical signal from moving averages and strong analyst support. The company has consistently beaten earnings estimates in recent quarters, with Q3 2026 results pending. Revenue grew to $24.57B in 2025, though net margins have compressed from historical highs. A quarterly dividend of $0.40 was declared, payable in October 2026.

The outlook remains positive given earnings momentum and institutional accumulation, but valuation multiples are elevated. Risks include margin pressure and high capital expenditure in 2026. The consensus price target of $230.31 implies modest upside, supported by 70% buy ratings from analysts.

Western Alliance Bancorporation

Western Alliance Bancorporation (WAL) trades at $74.35, down 2.29% on the day, with a bearish technical outlook despite strong fundamentals. The company maintains robust profitability with 25.43% net income margin and 13.43% ROE, supported by recent earnings beats in Q4 2025 and Q1 2026. Recent developments include the launch of WA VenueX digital asset platform and participation in major financial conferences, while institutional investors show mixed positioning.

WAL presents a compelling value opportunity with attractive valuation multiples (P/E 8.39, P/B 1.07) and strong analyst support (79% buy ratings, $84.33 consensus target). However, near-term risks include the recent Q2 2026 EPS miss, bearish technical indicators, and regulatory uncertainty around Fed policy changes affecting bank asset thresholds.

Returns comparison

Trailing returns across standard periods

Investor sentiment on Pluang

What Pluang investors did over the last 30 days

DHR
18% Buy82% Sell
Avg holding period · 69 Days
WAL

No sentiment data available yet.

Top news

Latest headlines on both assets

About Danaher Corporation

In 1984, Danaher's founders transformed a real estate organization into an industrial-focused manufacturing company. Through a series of mergers, acquisitions, and divestitures, including the Fortive separation in 2016, Danaher now focuses primarily on manufacturing scientific instruments and consumables in three segments: life sciences, diagnostics, and environmental and applied solutions. In late 2019, Danaher separated from its dental business through an initial public offering process, and in early 2020, it acquired GE's Biopharma business, now called Cytiva, which added to its life sciences segment.

Read more on DHR →

About Western Alliance Bancorporation

Western Alliance Bancorporation is a top-performing bank holding company that operates a dual business model: high-touch regional banking and specialized national business lines. It serves niche industries—including technology, life sciences, and homeowners associations—providing sophisticated commercial lending and treasury solutions that bridge the gap between regional service and national scale.

Read more on WAL →